J&J | JNJ - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 608K 2026-06
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Baxter International USD 517M 549K 2026-06
Bayer EUR 982.42M 0 2026-09
Becton, Dickinson and Co. USD 272.39M 98.21M 2026-09
Biogen USD 146.7M 200K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bristol-Myers Squibb USD 2.04B 7M 2026-06
CONMED USD 29.87M 118K 2026-09
Cooper Companies USD 190.1M 5.01M 2026-06
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 576.6M 400K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Globus Medical USD 132.66M 1.59M 2026-09
Insulet USD 69.37M 16K 2026-09
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 353.28M 885K 2026-09
J&J USD 2.41B 1.64M 2026-06
Medtronic USD 1.28B 130K 2026-06
Merck USD 2.47B 1.05M 2026-06
Merit Medical Systems USD 59.71M 55K 2026-06
Novartis USD 1.89B 12.09M 2026-09
Pfizer USD 5.7B 1000K 2026-09
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 0 2026-09
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.76M 217K 2026-09
Teva Pharmaceutical Industries USD 1.17B 2M 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Zimmer Biomet Holdings USD 190.1M 3.3M 2026-09
Zoetis USD 407.49M 6.67M 2026-09